Glucose News and Research

RSS

Fat tissue could be a source of diabetes, shows new research

A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional focus on liver and pancreas as the main culprits.

12 Oct 2018

Study shows that one amino acid may produce short-term lowering of glucose levels

Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins.

11 Oct 2018

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

11 Oct 2018

ASPEN, Baxter launch educational video series on appropriate use of parenteral nutrition

Today the American Society for Parenteral and Enteral Nutrition, an organization which drives the science and practice of clinical nutrition, and Baxter International Inc., a global leader in clinical nutrition, launched an educational video series on the appropriate use of parenteral nutrition, as part of the organizations' "SmartPN" collaboration to help reduce clinical malnutrition that was announced last year.

10 Oct 2018

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.

10 Oct 2018

Researchers show possibility to restore insulin cell function in type 2 diabetes

By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown that it is possible to prevent the development of the disease.

8 Oct 2018

Researchers streamline design of lab-on-a-chip devices to observe their inner workings

Microfluidic devices can take standard medical lab procedures and condenses each down to a microchip that can balance on top of a water bottle lid.

6 Oct 2018

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Boehringer Ingelheim and Eli Lilly and Company today presented the full results of the long-term cardiovascular outcome trial, CARMELINA®, which studied the impact of Trajenta® (linagliptin) on cardiovascular and kidney safety in adults with type 2 diabetes at high risk for heart and/or kidney disease.

5 Oct 2018

Tarragon and bitter melon supplements may be less helpful for women than men

Russian tarragon and bitter melon supplements may be less helpful for women than men when it comes to combating metabolic syndrome, whose symptoms include high blood sugar, high blood pressure and excess fat around the waist.

5 Oct 2018

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction Study Group presented diabetes-related findings from CAMELLIA-TIMI 61, a clinical trial of overweight and obese patients designed to test lorcaserin, a weight loss drug manufactured by the trial's sponsor, Eisai Inc.

4 Oct 2018

Discovery opens door to new therapies for type 1 diabetes

Researchers at St Vincent’s Institute in Melbourne have identified a key target of the immune response that causes type 1 diabetes.

4 Oct 2018

Yo-yo dieting increases risk of heart attack and stroke, finds study

In the study, sudden changes in metabolic health parameters were associated with a raised risk of heart attacks, strokes and even early deaths.

4 Oct 2018

Newly discovered compounds may explain whole grain health benefits

Scientists have discovered new compounds that may explain whole grain health benefits, reports a new study led by the University of Eastern Finland.

3 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018

Novel method promises to reduce production costs for potent form of vitamin K

In an innovative study that promises to reduce production costs for the most potent form of vitamin K -- Menaquinone-7, Penn State researchers have developed a novel method to enhance the fermentation process that creates the supplement by agitated liquid fermentation in a biofilm reactor.

3 Oct 2018

Gene variant linked to Type 2 diabetes may predispose people to have lower body weight

A research team at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health found that a well-known gene variant linked to Type 2 diabetes, called transcription Factor-7 like 2 gene, may also predispose someone to being leaner, or having a lower body weight.

3 Oct 2018

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Researchers used continuous glucose monitoring to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes and found significant reductions in mean glucose and other glycemic factors, with greater improvements seen in patients taking metformin compared to insulin.

3 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

Glucose News and Research

Fat tissue could be a source of diabetes, shows new research

Study shows that one amino acid may produce short-term lowering of glucose levels

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

ASPEN, Baxter launch educational video series on appropriate use of parenteral nutrition

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

Researchers show possibility to restore insulin cell function in type 2 diabetes

Researchers streamline design of lab-on-a-chip devices to observe their inner workings

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Tarragon and bitter melon supplements may be less helpful for women than men

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Discovery opens door to new therapies for type 1 diabetes

Yo-yo dieting increases risk of heart attack and stroke, finds study

Newly discovered compounds may explain whole grain health benefits

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

Novel method promises to reduce production costs for potent form of vitamin K

Gene variant linked to Type 2 diabetes may predispose people to have lower body weight

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News